105 Followers on Owler

Dermira

Dermira develops and commercializes therapeutics for the treatment of dermatological diseases. Read more

Andrew Hotchkiss's photo - CEO of Dermira

CEO

Andrew Hotchkiss

CEO Approval Rating

81/100

DERMIRA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Hapten Sciences is the top competitor of Dermira. Hapten Sciences is headquartered in Memphis, Tennessee, and was founded in 2010. Hapten Sciences competes in the Life Sciences field. Hapten Sciences generates 24% the revenue of Dermira.

Dermata is perceived as one of Dermira's biggest rivals. Dermata was founded in San Diego, California} in 2014. Like Dermira, Dermata also operates in the Biotechnology industry. Compared to Dermira, Dermata generates $70.4M less revenue.

Arcutis is seen as one of Dermira's top competitors. Arcutis is a Public company that was founded in Westlake Village, California in 2016. Like Dermira, Arcutis also works within the Pharmaceuticals industry. Arcutis has 279 fewer employees vs. Dermira.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $82.9M a good estimate for Dermira's revenue?

Dermira Acquisitions

No recent acquisitions found related to Dermira

Dermira Funding History

Since Dermira was founded in 2010, it has participated in 9 rounds of funding. In total Dermira has raised $315.0M. Dermira's last funding round was on Dec 2018 for a total of $1.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Dec 2018
$1M
-
Equity
Dec 2017
$500K
-
Equity
Aug 2016
$1.5M
-
IPO
Oct 2014
$125M
-
Series C
Aug 2014
$51M

Since Dermira was founded in 2010, it has participated in 9 rounds of funding. In total Dermira has raised $315.0M. Dermira's last funding round was on Dec 2018 for a total of $1.0M

Dermira Investments

No recent investments found related to Dermira

Dermira News

October 23, 2020The Business Journals: San Francisco Business Times

Months after $1 billion buyout, Peninsula company, Lilly face generic challenge

Perrigo wants to sell a lower-cost generic form of Qbrexza, a pre-moistened cloth that treats abnorma... See more »
March 19, 2020TheMarketsDaily

Reviewing Dermira (NASDAQ:DERM) and Neurotrope (NASDAQ:NTRP

Dermira (NASDAQ:DERM) and Neurotrope (NASDAQ:NTRP) are both small-cap medical companies, but which is... See more »
March 2, 2020MarketScreener

Form 15-12B - Securities Registration Termination

(marketscreener.com) 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 F... See more »
February 21, 2020FinSMEs

Eli Lilly and Company Closes Acquisition of Dermira

Eli Lilly and Company (NYSE: LLY) completed its acquisition of Dermira, Inc. (NASDAQ: DERM). The acqu... See more »
February 20, 2020MarketScreener

SEC Filing - POS AM

(marketscreener.com) POS AM As filed with the Securities and Exchange Commission on February 20, 2020... See more »
February 20, 2020FirstWord Pharma

Lilly Completes Acquisition of Dermira

INDIANAPOLIS, Feb. 20, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the suc... See more »

Dermira Press Releases

February 21, 2019GlobalNewswire

Dermira to Present at the 8th Annual SVB Leerink Global Healthcare Conference

MENLO PARK, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutic... See more »
February 12, 2019GlobeNewswire

Almirall and Dermira Enter into Option and License Agreement for European Rights to Lebrikizumab

- Almirall acquires option to license rights to develop and commercialize lebrikizumab for atopic der... See more »
December 13, 2018Business Wire

Axillary Hyperhidrosis Pipeline Insight Report, 2018 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Axillary Hyperhidrosis - Pipeline Insight, 2018" drug pipelines has bee... See more »
December 11, 2018StreetInsider

Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to ... See more »
December 4, 2018GlobeNewswire

Dermira Enters into Credit Facility with Athyrium Capital Management

Facility provides additional financial flexibility in connection with ongoing QBREXZA launch and lebr... See more »
November 19, 2018GlobeNewswire

Dermira to Present at Evercore ISI HealthCONx Conference

MENLO PARK, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutic... See more »
November 8, 2018StreetInsider

Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to ... See more »

Dermira Videos

December 20, 2017Dermira Vimeo Channel

"Dermira-VideoVignette-Hans_120417_v5" on VIMEO

Cast: Dermira... See more »
December 12, 2017Dermira Vimeo Channel

"Science of Sweat Animation_MP4" on VIMEO

Cast: Dermira... See more »

Social Media

Dermira Headquarters

275 Middlefield Road Suite 150

Menlo Park, California94025

650-421-7200

Driving Directions »

Trending Companies

Dermira Summary

ABOUT

Overview

Dermira develops and commercializes therapeutics for the treatment of dermatological diseases. Dermira was founded in 2010. Dermira's headquarters is located in Menlo Park, California, USA 94025. It has raised 315.0M in 9 rounds. The latest round was ...

CEO

Dermira's CEO, Andrew Hotchkiss, currently has an approval rating of 81%. Dermira's primary competitors are Hapten Sciences, Dermata & Arcutis.

Frequently Asked Questions about Dermira

  1. When was Dermira founded?

    Dermira was founded in 2010
  2. Who is Dermira's CEO?

    Dermira's CEO is Andrew Hotchkiss
  3. How much revenue does Dermira generate?

    Dermira generates $82.9M in revenue
  4. How much funding does Dermira have?

    Dermira has historically raised $315M in funding
  1. Where is Dermira's headquarters?

    Dermira's headquarters is in Menlo Park California, USA
  2. How many employees does Dermira have?

    Dermira has 333 employees
  3. What sector does Dermira operate in?

    Dermira is in Pharmaceuticals, Biotechnology
  4. Who are Dermira's competitors?

    Dermira's top competitors are Hapten Sciences, Dermata, Arcutis